To test this, we compared the effect of forodesine and dG treatment on peripheral blood mononuclear cells (PBMCs) from patients with CLL with or without acquired mutations in SAMHD1. This evidence concerns the gene SAMHD1 and B-cell chronic lymphocytic leukemia.